eclerx Services Ltd.

Size: px
Start display at page:

Download "eclerx Services Ltd."

Transcription

1 2017 Equirus All rights reserved Rating Information Price (Rs) 1,327 Target Price (Rs) 1,264 Target Date 31st Mar '18 Target Set On 13th Jan '17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 1,174 Fair Value (DDM) 86 Ind Benchmark BSE IT Model Portfolio Position NA Stock Information Market Cap (Rs Mn) 52,885 Free Float (%) % 52 Wk H/L (Rs) /1255 Avg Daily Volume (1yr) 37,150 Avg Daily Value (Rs Mn) 54 Equity Cap (Rs Mn) 398 Face Value (Rs) 10 Bloomberg Code ECLX IN Ownership Recent 3M 12M Promoters 50.3 % -0.2 % -0.1 % DII 12.0 % 0.2 % -2.1 % FII 30.7 % 1.1 % 3.6 % Public 7.0 % -1.1 % -1.4 % Price % 1M 3M 12M Absolute 2.1 % -1.5 % -6.9 % Vs Industry -5.1 % -0.9 % 4.1 % Hinduja Global -7.9 % % 26.2 % Firstsource % % % Consolidated Quarterly EPS forecast Rs/Share 1Q 2Q 3Q 4Q EPS (17A) EPS (18E) eclerx Services Ltd. Absolute : REDUCE Relative : Underweight 4QFY17Result: Estimate ( ), PT ( ), Rating ( ) Regular Coverage -1% Downside in 13 Months But for valuations. Retain REDUCE eclerx reported decent 4Q, relative to toned-down expectations, driven by growth in emerging clients while overall commentary was encouraging. eclerx highlighted that it is better prepared, today, to capitalize on existing demand driven by initiatives including client mining, near shore delivery, focus on expanding offerings (analytics) taken in FY17. That said, seasonality could vary as revenue headwinds are now expected in 2QFY18 vs. 1Q earlier. Management reiterated its about 30% EBITM guidance for FY18E despite the challenging environment. We are modestly raising our revenue estimates but are trimming our margin assumption driven by rupee, drag from project roll-offs and leads to cut in our target price. Maintain REDUCE with TP of Rs. 1,264 at 15x Jun 18 TTM EPS of Rs (Mar 18, Rs. 1,331, 15x earlier). Emerging clients to drive growth in FY18E: During FY17, top 10 customer revenues declined 4.9%/4.6% in $/CC terms while for emerging clients it grew 4.6%/8.5%, respectively. As for 4Q, top 5/6-10 revenues declined/grew 2.7%/6.1% while non-top 10 customer revenues grew 10% qoq. Commentary suggests momentum in emerging clients could continue in FY18E driven by pipeline build-up, whereas top client growth could be soft. Client counts in top 2 brackets ($5 mn+/$1 mn+) have declined/increased by 1 due to transitioning of a large customer. Visibility improving: eclerx highlighted that new contract wins were similar to FY16 but current pipeline, within emerging clients, is largest compared to the previous 4-5 quarters driven by recovery in financial services and momentum in digital offerings. Commentary also suggests a pickup in demand from banking clients in the next months. From a quarterly perspective, all quarters except 2Q could witness growth while 2Q revenues could decline (0 to -5%) qoq led by project roll-offs. Consequently, we are adjusting our estimates and expect a modest 1.6% yoy growth vs. 0.7% decline earlier. Margins softer than anticipated: EBITM expanded 151bps qoq to 29.5% - but were 46bps below EE (30%) driven by growth and decline in employee costs partially offset by higher SG&A expenses. Employee costs declined 1.7% qoq vs. our 0.7% decline estimate, while sales & distribution costs rose 2.5% qoq and G&A increased 1.7% qoq. eclerx guided for about 30% margins in FY18E driven by levers such as hedges, SG&A rationalization, and depreciation due to lower capex. That said, change in rupee/tax assumption leads to cut in in margin assumption/earnings. Retain REDUCE on rich valuations: Though shareholder value creation initiatives could anchor shares, EPS growth remains modest while valuations at 16.5x FY18E EPS remain rich. Retain REDUCE with TP of Rs. 1,264 at 15x Jun 18 TTM EPS of Rs Change in Estimates IT Services Revised Estimates % Change ` FY18E FY19E FY18E FY19E Sales ($ Mn) % 1.5% Sales 13,017 14, % -0.7% EBITDA 4,450 5, % -2.4% EBIT 3,871 4, % -2.9% PAT 3,279 3, % -2.6% EPS % -2.6% Consolidated Financials Rs. Mn YE Mar FY17A FY18E FY19E FY20E Sales 13,300 13,017 14,065 14,981 EBITDA 4,689 4,450 5,097 5,399 Depreciation Interest Expense Other Income Reported PAT 3,534 3,278 3,852 4,099 Recurring PAT 3,536 3,278 3,852 4,099 Total Equity 14,350 15,418 16,938 21,037 Gross Debt Cash 6,060 10,155 11,055 14,567 Rs Per Share FY17A FY18E FY19E FY20E Earnings Book Value Dividends FCFF P/E (x) P/B (x) EV/EBITDA (x) ROE (%) 28 % 22 % 24 % 22 % Core ROIC (%) 54 % 49 % 58 % 56 % EBITDA Margin (%) 35 % 34 % 36 % 36 % Net Margin (%) 27 % 25 % 27 % 27 % May 31, 2017 Analyst: Abhishek Shindadkar (abhishek.shindadkar@equirus.com ) Page 1 of 12 Before reading this report, you must refer to the disclaimer on the last page.

2 Key takeaways from the conference call Emerging clients to drive growth in FY18E, top could be soft. Stronger pipeline with emerging clients than past twelve months. Expect pickup in demand from banking clients in the next months. Opened first delivery centre in the US in North Carolina and New Houston office for Analytics. Delivered largest consulting and analytics related work at client locations. Revenue headwind to occur in 2QFY18 instead of Q1. Company retained its 30% EBITM guidance for FY18E Employee costs could remain elevated due to hike in wages (higher single digits for offshore staff and low single digit for onshore staff). Company has trained employees on robotics in Q4FY17 as planned earlier. Utilization declined 190bps qoq and could decline further due to pending roll-offs in 2QFY18. Attrition increased both qoq and yoy to 34%. ETR is lower in 4Q at 19% due to tax credit and could be 25% in FY18E as credits are exhausted. Capex was down compared to last year and expected to decrease in FY18 as the company has sufficient capacity in all development centres. One European client has changed the payment term from Euro to USD Other income decreased to loss ofrs. 72.6mn vs. profit of Rs mn qoq. Total hedge position at $ at strike rate of 72.1 INR/USD and 100% forwards. Dividend of Rs. 1 has been declared for FY17. May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 2 of 11

3 Quarterly Results Table (Consolidated) % Change Rs Mn Q4FY17 Q4FY17E Q3FY17 Q4FY16 Q4FY17E Q3FY17 Q4FY16 Net Sales ($ Mn) % 1.5% -5.7% Net Sales (Rs Mn) 3,315 3,157 3,247 3, % 2.1% -3.4% India Employee Cost 1,316 1,325 1,339 1, % -1.7% 7.5% G&A % 1.7% 2.4% Selling & Distribution % 2.5% 4.3% Comments Total Expenditures 2,199 2,075 2,203 2, % -0.2% 5.8% EBITDA 1,116 1,082 1,044 1, % 6.9% -17.6% Depreciation % 2.5% -10.9% EBIT , % 7.6% -18.4% Other Income % % % PBT 906 1,024 1,023 1, % -11.4% -29.3% Tax % 0.0% -41.3% Recurring PAT , % -13.5% -26.0% Extraordinaries Reported PAT , % -13.5% -26.1% EPS (Rs) % -13.5% -26.0% EBITDA Margin 33.7% 34.3% 32.1% 39.4% -60 bps 152 bps -578 bps EBIT Margin 29.5% 30.0% 28.0% 35.0% -46 bps 151 bps -543 bps PBT Margin 27.3% 32.4% 31.5% 37.3% -509 bps -416 bps bps PAT Margin 22.4% 25.9% 26.5% 29.3% -351 bps -406 bps -688 bps Tax Rate 17.9% 20.0% 15.8% 21.5% -213 bps 203 bps -366 bps May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 3 of 11

4 Exhibit 1: Key Metrics across quarters Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q $ revenue qoq growth(%) 4.7% -0.6% 2.0% 5.2% 2.1% 4.6% 14.0% 8.2% 3.2% -1.9% -1.2% -2.6% -3.5% 1.5% Net employee addition Attrition 31.8% 30.1% 24.6% 28.4% 29.0% 31.0% 31.1% 35.9% 36.6% 28.6% 30.4% 41.3% 33.1% 34.0% DSO (Billed revenues) Client concentration Top-5 Clients 74% 73% 71% 68% 66% 64% 57% 56% 58% 58% NR NR NR NR Top -10 Clients NA NA 88% 87% 87% 86% 78% 75% 77% 76% 74% 75% 76% 74% Geographic Concentration North America 74% 74% 73% 74% 78% 78% 72% 67% 67% 67% 66% 68% 69% 67% Europe 21% 22% 22% 23% 18% 18% 25% 29% 29% 30% 30% 29% 27% 28% ROW 5% 4% 5% 3% 3% 4% 3% 4% 4% 3% 4% 3% 4% 5% Growth Top 10 Clients NR NR NR 4% 2% 3% 3% 4% 5% -3% -3% -2% -1% -1% Non Top 10 Clients NR NR NR 14% 2% 13% 79% 23% -3% 2% 4% -4% -10% 11% North America 4.7% -0.6% 0.6% 6.7% 7.6% 4.6% 5.2% 0.7% 3.2% -1.9% -2.7% 0.4% -2.1% -1.5% Europe 4.7% 4.2% 2.0% 10.0% -20.1% 4.6% 58.3% 25.5% 3.2% 1.5% -1.2% -5.8% -10.1% 5.2% ROW 4.7% -20.4% 27.5% -36.9% 2.1% 39.5% -14.5% 44.3% 3.2% -26.4% 31.8% -26.9% 28.7% 26.9% May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 4 of 11

5 Company Snapshot How we differ from Consensus EPS Sales PAT - Equirus Consensus % Diff Comment FY18E % Consensus numbers before earnings FY19E % FY18E 13,017 13,522-4 % FY19E 14,065 14,926-6 % FY18E 3,278 3,562-8 % FY19E 3,852 3,987-3 % Our Key Investment arguments: Challenges across business segments like Financial Services (lower spending), Digital business (scaling issues and volatility) and Cables (now higher base) Ending of short term rollouts resulting in slower replenishment of revenues. Key Parameters FY17A FY18E FY19E FY20E Overall US$ Revenue USD-INR Rate Ending Headcount 8,737 8,837 9,037 9,237 Qtrly Revenue/employee 5,576 5,679 5,868 6,113 Utilization 68.5% 66.1% 66.8% 66.8% Selling and Marketing (% of Rev.) 12.9% 13.2% 11.9% 11.9% G&A (% of Rev.) 12.4% 12.1% 11.6% 11.6% EBIT Margin (%) 31.4% 29.7% 31.7% 31.7% PBT Margin (%) 32.8% 33.1% 35.6% 35.5% PAT Margin (%) 26.6% 25.2% 27.4% 27.4% Risk to Our Negative View: Rupee depreciation, revival in top clients, higher quantum digital wins, better than expected operating efficiency Acquisitions, Revival in key segments, Further penetration into Europe with CLX synergies, lower offshore employee costs Sensitivity to Key Variables % Change % Impact on EPS Rupee Appreciation 1 % -40bps Utilization 1 % +50bps DCF Valuations & Assumptions Rf Beta Ke Term. Growth Debt/IC in Term. Yr 6.9 % % 4.0 % 0.0 % - FY18E FY19E FY20-22E FY23-27E FY28-32E Sales Growth -2 % 8 % 6 % 4 % 5 % NOPAT Margin 23 % 24 % 23 % 21 % 20 % IC Turnover RoIC 49.0 % 58.1 % 52.8 % 46.1 % 43.1 % Years of strong growth Valuation as on date (Rs) 1,026 1,122 1,071 1,068 1,099 Valuation as on 30 th Jun 18 1,124 1,230 1,174 1,171 1,204 Based on DCF, assuming 5 years of 5% Sales CAGR growth and 43% average ROIC, we derive current fair value of Rs. 1,099 and 30 th Jun 18 fair value of Rs. 1,204. Company Description: eclerx is a mid-tier BPO player offering a blend of BPO and KPO services to leading investment banks, a leading computer and computer peripherals manufacturer and a few other Fortune 500 companies in Cable and Telecom, e-retail segment and travel and tourism industry. Key Triggers Comparable valuation Mkt Cap Price Target EPS P/E BPS P/B RoE Div Yield Company Reco. CMP Rs. Mn. Target Date FY17A FY18E FY19E FY17A FY18E FY19E FY17A FY18E FY17A FY18E FY19E FY17A FY18E Eclerx REDUCE 1,327 52,885 1,264 31st Mar ' % 22 % 24 % 0.1 % 3.5 % Hinduja Global NR ,601 NA NA % 13 % 11 % 2.7 % 5.0 % Firstsource NA 33 22,296 NA NA % 10 % 11 % 0.0 % 0.0 % May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 5 of 11

6 Consolidated Quarterly Earnings Forecast and Key Drivers Rs in Mn 1Q17A 2Q17A 3Q17A 4Q17A 1Q18E 2Q18E 3Q18E 4Q18E 1Q19E 2Q19E 3Q19E 4Q19E FY17A FY18E FY19E FY20E Revenue 3,403 3,335 3,247 3,315 3,273 3,155 3,239 3,350 3,431 3,471 3,537 3,625 13,300 13,017 14,065 14,981 India Employee Cost 1,325 1,267 1,339 1,316 1,352 1,325 1,308 1,289 1,392 1,438 1,403 1,429 5,246 5,275 5,662 6,061 G&A ,647 1,569 1,635 1,741 Selling & Distribution ,718 1,723 1,671 1, EBITDA 1,260 1,270 1,044 1,116 1, ,129 1,273 1,233 1,226 1,294 1,344 4,689 4,450 5,097 5,399 Depreciation EBIT 1,140 1, ,119 1,077 1,069 1,135 1,184 4,170 3,871 4,465 4,742 Interest Other Income PBT 1,240 1,189 1, , ,100 1,243 1,200 1,199 1,273 1,330 4,358 4,313 5,002 5,324 Tax ,035 1,150 1,224 PAT bef. MI & Assoc ,024 3,536 3,278 3,852 4,099 Minority Interest Profit from Assoc Recurring PAT ,024 3,536 3,278 3,852 4,099 Extraordinaries Reported PAT ,024 3,534 3,278 3,852 4,099 EPS (Rs) Key Drivers $ revenue Employee Headcount Increase Average $-Rs exchange rate Sequential Growth (%) Revenue -1 % -2 % -3 % 2 % -1 % -4 % 3 % 3 % 2 % 1 % 2 % 2 % India Employee Cost 8 % -4 % 6 % -2 % 3 % -2 % -1 % -1 % 8 % 3 % -2 % 2 % EBITDA -7 % 1 % -18 % 7 % -6 % -6 % 14 % 13 % -3 % -1 % 6 % 4 % EBIT -5 % 0 % -20 % 8 % -7 % -7 % 15 % 14 % -4 % -1 % 6 % 4 % Recurring PAT -5 % 1 % -11 % -14 % 3 % -5 % 14 % 13 % -2 % 0 % 6 % 4 % EPS -5 % 1 % -11 % -14 % 3 % -5 % 14 % 13 % -2 % 0 % 6 % 4 % Yearly Growth (%) Revenue 14 % 2 % -6 % -3 % -4 % -5 % 0 % 1 % 5 % 10 % 9 % 8 % 1 % -2 % 8 % 7 % EBITDA 21 % 7 % -15 % -18 % -16 % -22 % 8 % 14 % 17 % 23 % 15 % 6 % -2 % -5 % 15 % 6 % EBIT 23 % 10 % -15 % -18 % -20 % -25 % 8 % 14 % 18 % 25 % 16 % 6 % -2 % -7 % 15 % 6 % Recurring PAT 27 % 19 % 1 % -26 % -20 % -25 % -3 % 27 % 21 % 26 % 17 % 8 % 3 % -7 % 18 % 6 % EPS 27 % 19 % 1 % -26 % -20 % -25 % -3 % 27 % 21 % 26 % 17 % 8 % 3 % -7 % 18 % 6 % Margin (%) EBITDA 37 % 38 % 32 % 34 % 32 % 32 % 35 % 38 % 36 % 35 % 37 % 37 % 35 % 34 % 36 % 36 % EBIT 34 % 34 % 28 % 30 % 28 % 27 % 30 % 33 % 31 % 31 % 32 % 33 % 31 % 30 % 32 % 32 % PBT 36 % 36 % 31 % 27 % 31 % 30 % 34 % 37 % 35 % 35 % 36 % 37 % 33 % 33 % 36 % 36 % PAT 28 % 29 % 27 % 22 % 23 % 23 % 26 % 28 % 27 % 27 % 28 % 28 % 27 % 25 % 27 % 27 % May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 6 of 11

7 Mar-08 Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar/08 Mar/09 Mar/10 Mar/11 Mar/12 Mar/13 Mar/14 Mar/15 Mar/16 Mar/17 Mar/18 Consolidated Financials P&L (Rs Mn) FY17A FY18E FY19E FY20E Balance Sheet (Rs Mn) FY17A FY18E FY19E FY20E Cash Flow (Rs Mn) FY17A FY18E FY19E FY20E Revenue 13,300 13,017 14,065 14,981 Equity Capital PBT 4,358 4,313 5,002 5,324 Op. Expenditure 8,612 8,567 8,968 9,582 Reserve 11,744 15,010 16,530 20,629 Depreciation EBITDA 4,689 4,450 5,097 5,399 Networth 12,152 15,418 16,938 21,037 Others Depreciation Long Term Debt Taxes Paid 822 1,035 1,150 1,224 EBIT 4,170 3,871 4,465 4,742 Def Tax Liability Change in WC -1,236 1, Interest Expense Minority Interest Operating C/F 2,817 5,006 4,331 4,612 Other Income Account Payables Capex ,100-1,100 PBT 4,358 4,313 5,002 5,324 Other Curr Liabi 1,267 1,132 1,223 1,303 Change in Invest Tax 822 1,035 1,150 1,224 Total Liabilities & Equity 13,568 16,729 18,353 22,545 Others PAT bef. MI & Assoc. 3,536 3,278 3,852 4,099 Net Fixed Assets 2,521 2,842 3,160 3,502 Investing C/F ,100-1,100 Minority Interest Capital WIP Change in Debt Profit from Assoc Others Change in Equity Recurring PAT 3,536 3,278 3,852 4,099 Inventory Others ,209-2,332 0 Extraordinaires Account Receivables 1,895 1,783 1,927 2,052 Financing C/F ,209-2,332 0 Reported PAT 3,534 3,278 3,852 4,099 Other Current Assets 2,499 1,356 1,467 1,578 Net change in cash 2,799 1, ,512 FDEPS (Rs) Cash 6,060 10,155 11,055 14,567 RoE (%) 28 % 22 % 24 % 22 % DPS (Rs) Total Assets 13,568 16,729 18,353 22,545 RoIC (%) 28 % 22 % 24 % 22 % CEPS (Rs) Non-cash Working Capital 2,998 1,848 2,000 2,145 Core RoIC (%) 54 % 49 % 58 % 56 % FCFPS (Rs) Cash Conv Cycle Div Payout (%) 1 % 67 % 61 % 0 % BVPS (Rs) WC Turnover P/E EBITDAM (%) 35 % 34 % 36 % 36 % FA Turnover P/B PATM (%) 27 % 25 % 27 % 27 % Net D/E P/FCFF Tax Rate (%) 19 % 24 % 23 % 23 % Revenue/Capital Employed EV/EBITDA Sales Growth (%) 1 % -2 % 8 % 7 % Capital Employed/Equity EV/Sales FDEPS Growth (%) 3 % -7 % 18 % 6 % Dividend Yield (%) 0.1 % 3.5 % 3.7 % 0.0 % TTM P/E vs. 2 yr forward EPS growth TTM P/B vs. 2 yr forward RoE ROE 2,000 40% 20x 65% 8x EPS Growth 35% 3,000 1,600 18x 30% 2,500 55% 6x 1,200 25% 15x 2,000 20% x 1,500 45% 4x 15% 10% 8x 1,000 3x % 5% 500 2x - 0% - 25% May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 7 of 11

8 Historical Consolidated Financials P&L (Rs Mn) FY14A FY15A FY16A FY17A Balance Sheet (Rs Mn) FY14A FY15A FY16A FY17A Cash Flow (Rs Mn) FY14A FY15A FY16A FY17A Revenue 8,410 9,421 13,143 13,300 Equity Capital PBT 3,316 2,978 4,510 4,358 Op. Expenditure 4,874 6,266 8,337 8,612 Reserve 5,588 6,847 10,455 13,942 Depreciation EBITDA 3,536 3,155 4,806 4,689 Networth 5,889 7,150 10,863 14,350 Others Depreciation Long Term Debt Taxes Paid , EBIT 3,206 2,654 4,240 4,170 Def Tax Liability Change in WC ,236 Interest Expense Minority Interest Operating C/F 1,950 2,432 3,846 2,817 Other Income Account Payables Capex , PBT 3,316 2,978 4,510 4,358 Other Curr Liabi 1,746 2,192 1,318 1,267 Change in Invest Tax , Total Liabilities & Equity 7,914 9,592 12,654 15,766 Others PAT bef. MI & Assoc. 2,557 2,295 3,429 3,536 Net Fixed Assets 1,548 1,670 3,398 2,521 Investing C/F , Minority Interest Capital WIP Change in Debt Profit from Assoc Others Change in Equity Recurring PAT 2,557 2,295 3,429 3,536 Inventory Others , Extraordinaires Account Receivables 996 1,261 1,861 1,895 Financing C/F , Reported PAT 2,557 2,295 3,429 3,534 Other Current Assets 1,581 1,510 1,352 2,499 Net change in cash ,091 2,799 EPS (Rs) Cash 3,560 4,419 5,459 6,060 RoE (%) 50 % 35 % 38 % 28 % DPS (Rs) Total Assets 7,914 9,591 12,654 13,568 RoIC (%) 49 % 35 % 37 % 28 % CEPS (Rs) Non-cash Working Capital ,762 2,998 Core RoIC (%) 110 % 71 % 70 % 54 % FCFPS (Rs) Cash Conv Cycle Div Payout (%) 48 % 54 % 1 % 1 % BVPS (Rs) WC Turnover P/E EBITDAM (%) 42 % 33 % 37 % 35 % FA Turnover P/B PATM (%) 30 % 24 % 26 % 27 % Net D/E P/FCFF Tax Rate (%) 23 % 23 % 24 % 19 % Revenue/Capital Employed EV/EBITDA Sales growth (%) 27 % 12 % 40 % 1 % Capital Employed/Equity EV/Sales FDEPS growth (%) 49 % -10 % 49 % 3 % Dividend Yield (%) 2.6 % 2.6 % 0.1 % 0.1 % May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 8 of 11

9 Equirus Securities Research Analysts Sector/Industry Equity Sales Abhishek Shindadkar IT Services Vishad Turakhia Ashutosh Tiwari Auto, Metals & Mining Subham Sinha Depesh Kashyap Mid-Caps Sweta Sheth Devam Modi Power & Infrastructure Viral Desai Dhaval Dama FMCG, Mid-Caps Binoy Dharia Manoj Gori Consumer Durables Dealing Room Maulik Patel Oil and Gas Ashish Shah Rohan Mandora Banking & Financial Services Ilesh Savla Associates Manoj Kejriwal Ankit Choudhary Rohit Rajani Bharat Celly Sandip Amrutiya Harshit Patel Compliance Officer Meet Chande Jay Soni Parva Soni Pranav Mehta Ronak Soni Vikas Jain Rating & Coverage Definitions: Absolute Rating LONG : Over the investment horizon, ATR >= Ke for companies with Free Float market cap >Rs 5 billion and ATR >= 20% for rest of the companies ADD: ATR >= 5% but less than Ke over investment horizon REDUCE: ATR >= negative 10% but <5% over investment horizon SHORT: ATR < negative 10% over investment horizon Relative Rating OVERWEIGHT: Likely to outperform the benchmark by at least 5% over investment horizon BENCHMARK: likely to perform in line with the benchmark UNDERWEIGHT: likely to under-perform the benchmark by at least 5% over investment horizon Registered Office: Equirus Securities Private Limited Unit No. 1201, 12th Floor, C Wing, Marathon Futurex, N M Joshi Marg, Lower Parel, Mumbai Tel. No: +91 (0) Fax No: +91- (0) Investment Horizon Investment Horizon is set at a minimum 3 months to maximum 18 months with target date falling on last day of a calendar quarter. Lite vs. Regular Coverage vs. Spot Coverage We aim to keep our rating and estimates updated at least once a quarter for Regular Coverage stocks. Generally, we would have access to the company and we would maintain detailed financial model for Regular coverage companies. We intend to publish updates on Lite coverage stocks only an opportunistic basis and subject to our ability to contact the management. Our rating and estimates for Lite coverage stocks may not be current. Spot coverage is meant for one-off coverage of a specific company and in such cases, earnings forecast and target price are optional. Spot coverage is meant to stimulate discussion rather than provide a research opinion. Corporate Office: 3rd floor, House No. 9, Magnet Corporate Park, Near Zydus Hospital, B/H Intas Sola Bridge, S.G. Highway Ahmedabad Gujarat Tel. No: +91 (0) Fax No: +91 (0) May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 9 of 11

10 2017 Equirus Securities Private Limited. All rights reserved. For Private Circulation only. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Equirus Securities Private Limited Analyst Certification I,AbhishekShindadkar, author to this report, hereby certify that all of the views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Disclosures Equirus Securities Private Limited (ESPL) having Corporate Identification Number U65993MH2007PTC is registered in India with Securities and Exchange Board of India (SEBI) as a trading member on the Capital Market (Reg. No. INB ), Futures & Options Segment (Reg. No.INF ) of the National Stock Exchange of India Ltd. (NSE) and on Cash Segment (Reg. No.INB ) of Bombay Stock Exchange Limited (BSE).ESPL is also registered with SEBI as Research Analyst under SEBI (Research Analyst) Regulations, 2014 (Reg. No. INH ) and as Portfolio Manager under SEBI (Portfolio Managers Regulations, 1993 (Reg. No. INP ). There are no disciplinary actions taken by any regulatory authority against ESPL. ESPL is a subsidiary of Equirus Capital Pvt. Ltd. (ECPL) which is registered with SEBI as Category I Merchant Banker and provides investment banking services including but not limited to merchant banking services, private equity, mergers &acquisitions and structured finance. As ESPL and its associates are engaged in various financial services business, it might have: - (a) received compensation (except in connection with the preparation of this report) from the subject company for investment banking or merchant banking or brokerage services in the past twelve months;(b) managed or co-managed public offering of securities for the subject company in the past twelve months; or (c) have received a mandate from the subject company; or (d) might have other financial, business or other interests in entities including the subject company (ies) mentioned in this Report. ESPL & its associates, their directors and employees may from time to time have positions or options in the company and buy or sell the securities of the company (ies) mentioned herein. ESPL and its associates collectively do not own (in their proprietary position) 1% or more of the equity securities of the subject company mentioned in the report as the last day of the month preceding the publication of the research report. ESPL or its Analyst or Associates did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ESPL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ESPL has not been engaged in market making activity for the subject company. The Research Analyst engaged in preparation of this Report:- (a) has not received any compensation from the subject company in the past twelve months; (b) has not managed or co-managed public offering of securities for the subject company in the past twelve months; (c)has not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (d) has not received any compensation for products orservices other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (e) has not received any compensation or other benefits from the subjectcompany or third party in connection with the research report; (f) might have served as an officer, director or employee of the subject company; (g) is not engaged in market making activity for the subject company. This document is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ESPL and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession of this document are required to inform themselves of, and to observe, such applicable restrictions. Please delete this document if you are not authorized to view the same. By reading this document you represent and warrant that you have full authority and all rights necessary to view and read this document without subjecting ESPL and affiliates to any registration or licensing requirement within such jurisdiction. This document has been prepared solely for information purpose and does not constitute a solicitation to any person to buy, sell or subscribe any security. ESPL or its affiliates are not soliciting any action based on this report. The information and opinions contained herein is from publicly available data or based on information obtained in good faith from sources believed to be reliable but ESPL provides no guarantee as to its accuracy or completeness. The information contained herein is as on date of this report, and is subject to change or modification and any such changes could impact our interpretation of relevant information contained herein. While we would endeavour to update the information herein on reasonable basis, ESPL and its affiliates, their directors and employees are under no obligation to update or keep the information current. Also there may be regulatory, compliance, or other reasons that may prevent ESPL and its group companies from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document including the merits and risks involved. This document is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. ESPL and its group companies, employees, directors and agents accept no liability, and disclaim all responsibility, for the consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it. ESPL/its affiliates do and seek to do business with companies covered in its research report. Thus, investors should be aware that the firm may have conflict of interest. May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 10 of 11

11 A graph of daily closing prices of securities is available at and (Choose a company from the list on the browser and select the three years period in the price chart). Disclosure of Interest statement for the subject Company Yes/No If Yes, nature of such interest Research Analyst or Relatives financial interest Research Analyst or Relatives actual/beneficial ownership of 1% or more Research Analyst or Relatives material conflict of interest No No No Disclaimer for U.S. Persons ESPL/its affiliates are not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Equirus is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the Acts ), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Equirus, including the products and services described herein are not available to or intended for U.S. persons. The information contained in this Report is not intended for any person who is a resident of the United States of America or a resident of any jurisdiction, the laws of which imposes prohibition on soliciting the securities business in that jurisdiction without going through the registration requirements and/or prohibit the use of any information contained in this report. This Report and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. May 31, 2017 Analysts: AbhishekShindadkar (abhishek.shindadkar@equirus.com , ) Page 11 of 11

P&G Hygiene & Healthcare Ltd.

P&G Hygiene & Healthcare Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 8,015 Target Price (Rs) 8,965 Target Date 30 Jun 18 Target Set On 14 Jun 17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 8,965 Fair Value

More information

Greaves Cotton Ltd. Standalone Estimate Revision:

Greaves Cotton Ltd. Standalone Estimate Revision: Greaves Cotton Ltd. Absolute : REDUCE Relative : UNDERWEIGHT 2QFY18 Result : Estimate (), TP (), Rating () Regular Coverage 2% Upside in 14months Changing industry dynamics to shake up key business verticals

More information

Cera Sanitaryware Ltd.

Cera Sanitaryware Ltd. 2016 Equirus All rights reserved Rating Information Price (Rs) 1,980 Target Price (Rs) 2,312 Target Date 30th Jun'17 Target Set On 5th May'16 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,215 Fair

More information

Cipla Ltd. Absolute : ADD Relative : Benchmark. 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 5% ATR in 16 Months

Cipla Ltd. Absolute : ADD Relative : Benchmark. 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 5% ATR in 16 Months 2018EquirusAll rights reserved Rating Information Price (Rs) 520 Target Price (Rs) 547 Target Date 30th Sep'19 Target Set On 22nd May'18 Implied yrs of growth (DCF) 20 Fair Value (DCF) 543 Fair Value (DDM)

More information

DB Corp Equirus All rights reserved Rating Information Price (Rs) 375 Target Price (Rs) 480 Target Date

DB Corp Equirus All rights reserved Rating Information Price (Rs) 375 Target Price (Rs) 480 Target Date DB Corp Absolute : LONG Relative : Overweight 1QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 27% ATR in 14 Months Decent start to FY18, growth to accelerate in second half; retain LONG Media

More information

Bajaj Corp. Key risks: Lower than expected volume growth, increase in RM costs.

Bajaj Corp. Key risks: Lower than expected volume growth, increase in RM costs. 2017 Equirus All rights reserved Rating Information Price (Rs) 405 Target Price (Rs) 463 Target Date 30th Sep'18 Target Set On 13th July 17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 388 Fair Value

More information

Wipro Ltd. Change in estimates: Revised Estimates % Change FY18E FY19E FY18E FY19E

Wipro Ltd. Change in estimates: Revised Estimates % Change FY18E FY19E FY18E FY19E 2017 Equirus All rights reserved Rating Information Price (Rs) 297 Target Price (Rs) 267 Target Date 31st Dec '18 Target Set On 17th Oct '17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 270 Fair Value

More information

Lupin Ltd. Pharmaceuticals

Lupin Ltd. Pharmaceuticals 2017EquirusAll rights reserved Rating Information Price (Rs) 860 Target Price (Rs) 715 Target Date 31st Dec 18 Target Set On 07th Nov'17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 824 Fair Value (DDM)

More information

Solar Industries India

Solar Industries India Solar Industries India Absolute : ADD Relative : Overweight 4QFY18Result: Estimates(),PT(),Rating() Regular Coverage 9% ATR in 17 Months Strong 4Q led by international business; revise to ADD on earnings

More information

Tata Consultancy Services

Tata Consultancy Services 2017 Equirus All rights reserved Rating Information Price (Rs) 2,446 Target Price (Rs) 2,434 Target Date 30th Sep '18 Target Set On 14th July 17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,630 Fair

More information

Persistent Systems Ltd.

Persistent Systems Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 657 Target Price (Rs) 653 Target Date 30th Sep '18 Target Set On 23rd July 17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 793 Fair Value

More information

Domestic recovery on track, focus shifts on developing new brands upgrade to LONG on fair valuations Personal Care

Domestic recovery on track, focus shifts on developing new brands upgrade to LONG on fair valuations Personal Care Bajaj Corp Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 13% ATR in 14 Months Domestic recovery on track, focus shifts on developing new brands

More information

Torrent Power Limited

Torrent Power Limited Absolute : ADD Torrent Power Limited Relative : Overweight 2QFY18 Update: Estimate ( ), TP ( ), Rating ( ) Spot Coverage 7% ATR in 9 months Steady cash generation to continue; higher demand key to swing

More information

Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE

Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE Regular Coverage Absolute: REDUCE Relative: Benchmark 5% Downside

More information

Pokarna Ltd. Change in Estimates:

Pokarna Ltd. Change in Estimates: Pokarna Ltd. Absolute : LONG Relative : Overweight 3QFY16 Result : Estimate ( ), TP ( ), Rating ( ) Regular Coverage 57% ATR in 14 Months Stellar performance continues; Retain LONG as valuations are mouthwatering

More information

Wipro Ltd. Change in estimates: Revised Estimates % Change FY19E FY20E FY19E FY20E

Wipro Ltd. Change in estimates: Revised Estimates % Change FY19E FY20E FY19E FY20E 2018 Equirus All rights reserved Rating Information Price (Rs) 288 Target Price (Rs) 290 Target Date 31st Mar '19 Target Set On 25th Apr '18 Implied yrs of growth (DCF) 5 Fair Value (DCF) 253 Fair Value

More information

Maruti Suzuki India Limited

Maruti Suzuki India Limited Maruti Suzuki India Limited Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate (),PT (), Rating () Regular Coverage 13% ATR in 14 Months Margins impacted by one-offs, to normalize from 1QFY19-

More information

Strong sales momentum continues, however margins continue to remain at lower levels. Retain TRADE until clarity on margin improves

Strong sales momentum continues, however margins continue to remain at lower levels. Retain TRADE until clarity on margin improves 2016 Equirus All rights reserved Rating Information Price (Rs) 384 Target Price (Rs) 398 Target Date 30thSept 17 Target Set On 31stJuly'16 Implied yrs of growth (DCF) 20 Fair Value (DCF) 328 Fair Value

More information

TeamLease Services. Ownership Recent 3M 12M Promoters 40.8 % 0.0 % -2.4 % DII 5.7 % 0.8 % -9.1 % FII 43.9 % 3.6 % 22.8 % Public 9.6 % -4.3 % -11.

TeamLease Services. Ownership Recent 3M 12M Promoters 40.8 % 0.0 % -2.4 % DII 5.7 % 0.8 % -9.1 % FII 43.9 % 3.6 % 22.8 % Public 9.6 % -4.3 % -11. TeamLease Services Absolute: LONG Relative: Overweight 2QFY19 Result: Est. ( ), PT ( ), Rating ( ) Regular Coverage 12% ATR in 17 months One step forward; Upgrade to LONG as valuations turn reasonable

More information

Persistent Systems Ltd.

Persistent Systems Ltd. 2016 Equirus All rights reserved Rating Information Price (Rs) 666 Target Price (Rs) 645 Target Date 30th Sep '17 Target Set On 25th July '16 Implied yrs of growth (DCF) 5 Fair Value (DCF) 644 Fair Value

More information

Kajaria Ceramics Ltd.

Kajaria Ceramics Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 676 Target Price (Rs) 714 Target Date 30th Sep'18 Target Set On 21st May'17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 410 Fair Value

More information

Cadila Healthcare Ltd.

Cadila Healthcare Ltd. Cadila Healthcare Ltd. Absolute : Short Relative : Underweight Update Note: Estimate ( ), TP ( ), Rating ( ) Regular Coverage -7% ATR in 12 months USFDA raises concern in recently approved Sez facility

More information

Cadila Healthcare Ltd.

Cadila Healthcare Ltd. Cadila Healthcare Ltd. Absolute : Short Relative : Underweight 4QFY16 Results: Estimate (Ø), TP ( ), Rating ( ) Regular Coverage -8% ATR in 14 months Quarter Misses estimates; Muted earnings growth ahead

More information

Britannia Industries. Change in Estimates: Chg (%) FY17E Chg (%)

Britannia Industries. Change in Estimates: Chg (%) FY17E Chg (%) 2016 Equirus All rights reserved Rating Information Price (Rs) 2,634 Target Price (Rs) 3,546 Target Date 31 st Mar'17 Target Set On 11th Feb'16 Implied yrs of growth (DCF) 20 Fair Value (DCF) 2,292 Fair

More information

Wipro Ltd. Change in estimates:

Wipro Ltd. Change in estimates: 2018EquirusAll rights reserved Rating Information Price (Rs) 307 Target Price (Rs) 329 Target Date 31st Mar '20 Target Set On 24th Oct '18 Implied yrs of growth (DCF) 5 Fair Value (DCF) 298 Fair Value

More information

Fiem Industries Limited

Fiem Industries Limited Fiem Industries Limited Absolute: LONG Relative: Overweight 1QFY19 Result: Estimate ( ), PT ( ), Rating ( ) Regular Coverage 85% ATR in 11 Months LED benefit visible in Sales growth, margin should normalize

More information

Lupin Ltd. Pharmaceuticals

Lupin Ltd. Pharmaceuticals 2018 Equirus All rights reserved Rating Information Price (Rs) 751 Target Price (Rs) 759 Target Date 31st Mar 19 Target Set On 15th May'18 Implied yrs of growth (DCF) 20 Fair Value (DCF) 708 Fair Value

More information

lower realizations resulted in revenue growth of 9% yoy. Management during the AGM

lower realizations resulted in revenue growth of 9% yoy. Management during the AGM 2016EquirusAll rights reserved Rating Information Price (Rs) 1,922 Target Price (Rs) 2,147 Target Date 31stMar 17 Target Set On 31st July'16 Implied yrs of growth (DCF) 10 Fair Value (DCF) 1,509 Fair Value

More information

Kajaria Ceramics Ltd.

Kajaria Ceramics Ltd. Kajaria Ceramics Ltd. Absolute: LONG Relative: Benchmark 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 11% ATR in 17 months 2018 Equirus All rights reserved Rating Information Price

More information

Reliance Industries Ltd

Reliance Industries Ltd 217Equirus All rights reserved Rating Information Price (Rs) 996 Target Price (Rs) 1,45 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 746 Fair Value (DDM) 1,43 Ind Benchmark

More information

Sterlite Technologies Ltd.

Sterlite Technologies Ltd. 218 Equirus All rights reserved Rating Information Price (Rs) 336 Target Price (Rs) 41 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 441 Fair Value (DDM) 99 Ind Benchmark Model

More information

Cera Sanitaryware Ltd.

Cera Sanitaryware Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 3,322 Target Price (Rs) 3,538 Target Date 31st Mar'19 Target Set On 06th Nov'17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,447 Fair

More information

Apex Frozen Foods Ltd

Apex Frozen Foods Ltd Apex Frozen Foods Ltd Absolute : LONG Relative : Overweight 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 53% ATR in 14 Months Valuations attractive even on conservative guidance maintain

More information

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,032 Target Price (Rs) 1,116 Target Date

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,032 Target Price (Rs) 1,116 Target Date Minda Industries Absolute : ADD Relative Benchmark 2QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 8% ATR in 14 Months Futuristic product portfolio to drive strong growth maintain ADD Auto

More information

Petronet LNG Ltd. Change in Estimates:

Petronet LNG Ltd. Change in Estimates: 217 Equirus All rights reserved Rating Information Price (Rs) 27 Target Price (Rs) Target Date 31st Mar'19 Target Set On 9th Nov'17 Implied yrs of growth (DCF) 2 Fair Value (DCF) Fair Value (DDM) 61 Ind

More information

Jagran Prakashan Ltd. 2017EquirusAll rights reserved Rating Information Price (Rs) 173 Target Price (Rs) 200 Target Date

Jagran Prakashan Ltd. 2017EquirusAll rights reserved Rating Information Price (Rs) 173 Target Price (Rs) 200 Target Date Jagran Prakashan Ltd Absolute : LONG Relative : Overweight 3QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 15% ATR in 14 Months Weak quarter but green shoots of recovery emerging - maintain

More information

Reliance Industries Ltd

Reliance Industries Ltd 216 Equirus All rights reserved Rating Information Price (Rs) 1,39 Target Price (Rs) 1,138 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 1,18 Fair Value (DDM) 138 Ind Benchmark

More information

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,284 Target Price (Rs) 1,449 Target Date

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,284 Target Price (Rs) 1,449 Target Date Minda Industries Absolute : ADD Relative: Overweight 4QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 10% ATR in 16 Months Earnings growth momentum to continue, strong play on premiumization

More information

Gujarat Ambuja Exports

Gujarat Ambuja Exports Gujarat Ambuja Exports Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 31% ATR in 13 Months Focus shifts to profitable growth maintain LONG Agricultural

More information

Graphite India Ltd. Estimate Revision:

Graphite India Ltd. Estimate Revision: Absolute : TRADE Relative : BENCHMARK 4QFY14 Results : Estimate ( ), TP ( ), Rating ( ) Regular Coverage 11% upside in 14 Months Strong free cash flows in FY14 led by 26% reduction in WC days Metals &

More information

Margin disappointment likely quarter-specific; mid/long-term prospects intact retain LONG

Margin disappointment likely quarter-specific; mid/long-term prospects intact retain LONG Finolex Cables Ltd. Absolute : LONG Relative : Overweight 2QFY19 Results: Estimate( ), TP( ),Rating( ) Regular Coverage 18% ATR in 17 months Margin disappointment likely quarter-specific; mid/long-term

More information

VIP IndustriesLtd. Change in Estimates: Rs. Mn FY19E Chg (%) FY20E Chg (%) Sales 17,916 4% 21,129 6% EBITDA 2,572-3% 3,109-1% EPS % 14.

VIP IndustriesLtd. Change in Estimates: Rs. Mn FY19E Chg (%) FY20E Chg (%) Sales 17,916 4% 21,129 6% EBITDA 2,572-3% 3,109-1% EPS % 14. VIP IndustriesLtd. Absolute : LONG Relative : BENCHMARK 2QFY19 Result: Estimate(), TP(), Rating() Regular Coverage 17% ATR in 14months Volume growth momentum continues, demand outlook stays robust upgrade

More information

Manpasand Beverages Ltd.

Manpasand Beverages Ltd. 2015 Equirus All rights reserved Rating Information Primary Issue Size (Rs. Bn) 4.0 Face value (Rs.) 10.0 Issue type 100% Book building Ownership Pre-Issue Post-Issue Promoters 67.2 % 50.4 % Others 32.8

More information

Reliance Industries Ltd

Reliance Industries Ltd 217Equirus All rights reserved Rating Information Price (Rs) 1,13 Target Price (Rs) 1,188 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 812 Fair Value (DDM) 221 Ind Benchmark

More information

Finolex Industries Ltd.

Finolex Industries Ltd. Finolex Industries Ltd. Absolute: LONG Relative: OVERWEIGHT 2QFY19 Results: Estimates ( ), TP ( ), Rating ( ) Regular Coverage 24% ATR in 17 Months Beat driven by outperformance in PVC resin maintain LONG

More information

Infosys Ltd. IT Services

Infosys Ltd. IT Services 2019 Equirus All rights reserved Rating Information Price (Rs) 684 Target Price (Rs) 757 Target Date 31st Mar '20 Target Set On 12th Jan '19 Implied yrs of growth (DCF) 20 Fair Value (DCF) 732 Fair Value

More information

Sadbhav Engineering Limited

Sadbhav Engineering Limited Absolute : LONG Sadbhav Engineering Limited Relative : Overweight 4QFY17 Result: Estimate (), Target (), Rating () Regular Coverage 20% ATR in 13 Months 2017 Equirus All rights reserved Rating Information

More information

Century Plyboards India Ltd.

Century Plyboards India Ltd. z 218 Equirus All rights reserved Rating Information Price (Rs) 269 Target Price (Rs) 315 Target Date 3th Sep'19 Target Set On 6th Feb'18 Implied yrs of growth (DCF) 15 Fair Value (DCF) 231 Fair Value

More information

PVR Ltd. Media & Entertainment

PVR Ltd. Media & Entertainment PVR Ltd Absolute : LONG Relative : Overweight 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 17% ATR in 17 Months SPI Cinemas to accelerate growth trajectory for PVR maintain LONG Media

More information

Avanti Feeds Ltd. Vote for Equirus at Asiamoney Broker Poll'18

Avanti Feeds Ltd. Vote for Equirus at Asiamoney Broker Poll'18 Avanti Feeds Ltd Absolute : LONG Relative : Overweight FY18 Annual report analysis Regular Coverage 65% ATR in 15 Months Near-term headwinds persist, but all priced in retain LONG Consumer Discretionary

More information

PNC Infratech Limited

PNC Infratech Limited Absolute : LONG PNC Infratech Limited Relative : Overweight 4QFY16 Result: Estimate ( ), Target ( ), Rating ( ) Regular Coverage 26% ATR in 13 Months 2016 Equirus All rights reserved Rating Information

More information

Operating metrics stable, marginal uptick in slippages retain ADD

Operating metrics stable, marginal uptick in slippages retain ADD HDFC Bank Absolute :ADD Relative : Equal Weight 1QFY18 Result: Est. ( ), Target ( ), Rating ( ) Regular Coverage 7.6% ATR in 14 months Operating metrics stable, marginal uptick in slippages retain ADD

More information

PSP Projects Limited SDB Project: A Marvel In The Making!

PSP Projects Limited SDB Project: A Marvel In The Making! S 2018 Equirus All rights reserved PSP Projects Limited SDB Project: A Marvel In The Making! Site Visit We recently visited PSP s Surat Diamond Bourse (SDB) project to get an update on its progress and

More information

Karur Vysya Bank. Absolute: ADD Relative: Benchmark BFSI. Asset quality to remain under pressure; retain ADD

Karur Vysya Bank. Absolute: ADD Relative: Benchmark BFSI. Asset quality to remain under pressure; retain ADD 2017EquirusAll rights reserved Rating Information Price (Rs) 111 Target Price (Rs) 122 Target Date 31 st Mar 19 Target Set On 31 st Jan 18 Implied yrs of growth (ERE) 20 Fair Value (ERE) 122 Fair Value

More information

Equitas Holding. Absolute :REDUCE Relative : UNDERWEIGHT 1QFY18 Results: Est. ( ), Target ( ), Rating ( ) Regular Coverage 4% Downside in 14Months

Equitas Holding. Absolute :REDUCE Relative : UNDERWEIGHT 1QFY18 Results: Est. ( ), Target ( ), Rating ( ) Regular Coverage 4% Downside in 14Months Equitas Holding Absolute :REDUCE Relative : UNDERWEIGHT 1QFY18 Results: Est. ( ), Target ( ), Rating ( ) Regular Coverage 4% Downside in 14Months 2017Equirus All rights reserved Rating Information Price

More information

Cummins India Ltd Bloomberg Code: KKC IN

Cummins India Ltd Bloomberg Code: KKC IN Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn

More information

Cholamandalam Finance

Cholamandalam Finance Cholamandalam Finance Absolute: LONG Relative : OverWeight 4QFY18 Result: Est. ( ), Target ( ), Rating( ) Regular Coverage 16% ATR in 11 months Strong all-round performance; momentum to continue ahead

More information

NIIT Technologies. 3QFY19 Result Update. Robust revenue visibility, Outlook robust

NIIT Technologies. 3QFY19 Result Update. Robust revenue visibility, Outlook robust NIIT Technologies 3QFY19 Result Update Robust revenue visibility, Outlook robust Sector: Technology CMP: `1227 Recommendation: Buy Market statistics Current stock price (`) 1,227 Shares O/S (cr.) 6.1 Mcap

More information

Symphony Ltd. RESULT UPDATE 31st October 2017

Symphony Ltd. RESULT UPDATE 31st October 2017 . RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential

More information

Mphasis. 1QFY18 Result Update. Margins dip; valuations not supportive. Sector: Technology CMP: ` 614. Recommendation: Sell

Mphasis. 1QFY18 Result Update. Margins dip; valuations not supportive. Sector: Technology CMP: ` 614. Recommendation: Sell MphasiS 1QFY18 Result Update Margins dip; valuations not supportive Sector: Technology CMP: ` 614 Recommendation: Sell Market statistics Current stock price (`) 614 Shares O/S (cr.) 19.3 Mcap (` cr) 11,851

More information

NIIT Technologies. 2QFY19 Result Update. Robust revenue visibility, Outlook robust

NIIT Technologies. 2QFY19 Result Update. Robust revenue visibility, Outlook robust NIIT Technologies 2QFY19 Result Update Robust revenue visibility, Outlook robust Sector: Technology CMP: `1199 Recommendation: Buy Market statistics Current stock price (`) 1,199 Shares O/S (cr.) 6.1 Mcap

More information

Bloomberg Code: ATA IN

Bloomberg Code: ATA IN Auto OEM: 3-Wheelers Atul Feb Auto 03, 2015 Ltd India Research Stock Broking Bloomberg Code: ATA IN Stable quarter led by surge in exports volumes (TP revised ) : Operating revenue, EBITDA and PAT grew

More information

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x Gujarat Industries Power India Equity Research Power February 10, 2017 Result Update Emkay Your success is our success Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x CMP Target Price

More information

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research Increased confidence on margins July 25, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating BUY Price Rs540 Target Price Rs570 Implied Upside 5.6% Sensex 28,095 Nifty 8,636 (Prices as

More information

Tech Mahindra Ltd. RESULT UPDATE

Tech Mahindra Ltd. RESULT UPDATE Ltd. RESULT UPDATE 29 th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update - Q4FY17 II 29 th May, 2017 CMP INR 374 Target INR 473 Potential

More information

Bayer Cropscience (BYRCS IN)

Bayer Cropscience (BYRCS IN) (BYRCS IN) Rating: ACCUMULATE CMP: Rs4,258 TP: Rs4,517 February 4, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating ACCUMULATE

More information

Near-term pressure, but long-term outlook positive

Near-term pressure, but long-term outlook positive INDUSTRY IT CMP (as on 2 Nov 2015) Rs 1,812 Target Price Rs 2,050 Nifty 8,051 Sensex 26,559 KEY STOCK DATA Bloomberg ECLX IN No. of Shares (mn) 30 MCap (Rs bn) / ($ mn) 55/843 6m avg traded value (Rs mn)

More information

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E Company Update Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E EBITDA Margins recovered by 618 bps QoQ: The company has witnessed many challenges over the year FY17 starting

More information

Key estimate revision. Financial summary. Year

Key estimate revision. Financial summary. Year : price: EPS: How does our one year outlook change? We retain our positive outlook on WIL and believe that revival in MHCV industry, increasing content per vehicle and opportunity in exports would drive

More information

Tech Mahindra. 4QFY17 Result Update. Short term blip, compelling valuation. Sector: Technology CMP: ` 429. Recommendation: Buy

Tech Mahindra. 4QFY17 Result Update. Short term blip, compelling valuation. Sector: Technology CMP: ` 429. Recommendation: Buy Tech Mahindra 4QFY17 Result Update Short term blip, compelling valuation Sector: Technology CMP: ` 429 Recommendation: Buy Market statistics Current stock price (`) 429 Shares O/S (cr.) 97.1 Mcap (` cr)

More information

Visaka Industries Ltd

Visaka Industries Ltd Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%

More information

Tech Mahindra. 1QFY18 Result Update. Steps in the right direction, compelling valuation. Sector: Technology CMP: ` 385. Recommendation: Buy

Tech Mahindra. 1QFY18 Result Update. Steps in the right direction, compelling valuation. Sector: Technology CMP: ` 385. Recommendation: Buy Tech Mahindra 1QFY18 Result Update Steps in the right direction, compelling valuation Sector: Technology CMP: ` 385 Recommendation: Buy Market statistics Current stock price (`) 385 Shares O/S (cr.) 97.5

More information

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due

More information

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research Growth led by Enterprise Retain BUY October 26, 20 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Hussain Kagzi hussainkagzi@plindia.com +91 22 66322242 Rating BUY Price Rs669 Target Price Rs780

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research Strong growth in core services October 19, 2015 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Hussain Kagzi hussainkagzi@plindia.com +91 22 66322242 Rating BUY Price Rs494 Target Price Rs625

More information

Hexaware. 4QCY18 Result Update. Margin miss, rich valuations. Sector: Technology CMP: ` 322. Recommendation: Hold

Hexaware. 4QCY18 Result Update. Margin miss, rich valuations. Sector: Technology CMP: ` 322. Recommendation: Hold Hexaware 4QCY18 Result Update Margin miss, rich valuations Sector: Technology CMP: ` 322 Recommendation: Hold Market statistics Current stock price (`) 322 Shares O/S (cr.) 29.7 Mcap (` cr) 9,589 52W H/L

More information

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE 2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above

More information

Fineotex Chemical Ltd

Fineotex Chemical Ltd Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to

More information

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276 Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276 October 26, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E

More information

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 2904 Recommendation CMP Target Price BUY Rs. 312 Rs. 443 Better times ahead! reported a good set of numbers in

More information

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9, : price: EPS: How does our one year outlook change? We retain our positive view on EIM on the back of expected improvement in volume and margin at Royal Enfield (RE) and expected revival in VECV on the

More information

Havells India. Q4FY17 Result Update Strong Sales growth; Margins stable. Sector: Consumer Durable CMP: ` 515. Recommendation: BUY

Havells India. Q4FY17 Result Update Strong Sales growth; Margins stable. Sector: Consumer Durable CMP: ` 515. Recommendation: BUY Havells India Q4FY17 Result Update Strong Sales growth; Margins stable Sector: Consumer Durable CMP: ` 515 Recommendation: BUY Market statistics Current stock price (`) 515 Shares O/S (cr.) 62.5 Mcap (`

More information

ITC Ltd. RESULT UPDATE 27th October, 2017

ITC Ltd. RESULT UPDATE 27th October, 2017 . RESULT UPDATE 27th October, 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update - II 27th October, 2017 CMP INR 269 Target INR 349 Potential Upside

More information

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined

More information

Tech Mahindra. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research Margin beat driven by Headcount reduction November 01, 2017 Madhu Babu madhubabu@plindia.com +91 22 66322300 Rating BUY Price Rs489 Target Price Rs535 Implied Upside 9.4% Sensex 33,600 Nifty 10,441 (Prices

More information

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E. At inflection point Q2FY18 adjusted PAT grew 12% YoY at Rs 27 bn (vs. our estimate Rs 26 bn) in tandem with 17% YoY rise in regulated equity. Core RoE is still healthy at 20.2% though it contracted ~174

More information

Initiating Coverage. Uflex Ltd.

Initiating Coverage. Uflex Ltd. 2904 Recommendation CMP Target Price BUY Rs. 283 Rs. 444 Better times ahead! reported a good set of numbers for the year FY18 and for Q4. Sales for the quarter increase by 11.8% YoY to Rs 1809.8 Cr and

More information

Q4 EARNINGS REPORT Welspun India 25 Apr 17

Q4 EARNINGS REPORT Welspun India 25 Apr 17 Dec-11 Apr-12 Aug-12 Dec-12 Apr-13 Aug-13 Dec-13 Apr-14 Aug-14 Dec-14 Apr-15 Aug-15 Dec-15 Apr-16 Aug-16 Dec-16 Q4 EARNINGS REPORT Welspun India 25 Apr 17 CMP (Rs) 94 TP (Rs) 112 Maintain Outperformer

More information

Balkrishna Industries Ltd

Balkrishna Industries Ltd RESULT UPDATE 3 rd August 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

NIIT Technologies. 4QFY17 Result Update. Robust revenue visibility, Margin expansion story intact. Sector: Technology CMP: `471. Recommendation: Buy

NIIT Technologies. 4QFY17 Result Update. Robust revenue visibility, Margin expansion story intact. Sector: Technology CMP: `471. Recommendation: Buy NIIT Technologies 4QFY17 Result Update Robust revenue visibility, Margin expansion story intact Sector: Technology CMP: `471 Recommendation: Buy Market statistics Current stock price (`) 471 Shares O/S

More information

Larsen & Toubro (LT IN)

Larsen & Toubro (LT IN) (LT IN) Rating: BUY CMP: Rs1,321 TP: Rs1,566 July 25, 2018 Company Report Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price 1,566

More information

Institutional Equities

Institutional Equities 4QFY18 Result Update Institutional Equities Atul Auto 30 May 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Mar Profitability Atul Auto s (AAL) 4QFY18 earnings missed our expectations on account

More information

Dr Reddy s Laboratories

Dr Reddy s Laboratories : price: EPS: How does our one year outlook change? We maintain rating on DRRD post the company s 3QFY16 results Revenue growth for the quarter was muted (3% yoy) due to disappointing performances in Russia

More information

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2, : price: EPS: How does our one year outlook change? We maintain our negative stance on SKF India due to the absence of significant growth momentum drivers over the medium term. While railways could be

More information

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research Growth/margin bottoming May 25, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs704 Target Price Rs928 Implied Upside 31.8%

More information

KDDL (KDDL IN) In expansion mode

KDDL (KDDL IN) In expansion mode INSTITUTIONAL EQUITY RESEARCH KDDL (KDDL IN) In expansion mode INDIA MIDCAP Quarterly Update Top takeaways from 2QFY19 Results in line, recovery in manufacturing & strong growth in precision engineering.

More information

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018 RESULT UPDATE 8 th June, 2018 Sep-15 Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 India Equity Institutional Research II Result Update - Q4FY18 II 8 th June, 2018 2 Under Expansion Mode CMP

More information

Infosys. 3QFY19 Result Update. Decent quarter; Strong deal wins. Sector: Technology CMP: ` 684. Recommendation: Buy

Infosys. 3QFY19 Result Update. Decent quarter; Strong deal wins. Sector: Technology CMP: ` 684. Recommendation: Buy Infosys 3QFY19 Result Update Decent quarter; Strong deal wins Sector: Technology CMP: ` 684 Recommendation: Buy Market statistics Current stock price (`) 684 Shares O/S (cr.) 436.9 Mcap (` cr) 298,684

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Healthy operating performance; Accumulate October 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs5,860 Target Price Rs6,356 Implied Upside 8.5% Sensex 27,916 Nifty

More information